Brinda Balakrishnan

Brinda Balakrishnan

Direktor/Vorstandsmitglied bei AURINIA PHARMACEUTICALS INC.

Vermögen: 85 337 $ am 30.04.2024

44 Jahre
Health Technology
Finance
Consumer Services

Ursprung des Netzwerks ersten Grades von Brinda Balakrishnan

EinheitArt der EinheitIndustrie
Public Company Biotechnology 65
Public Company Biotechnology 28
2
Private Company Pharmaceuticals: Major 2

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Brinda Balakrishnan

UnternehmenSektorVerknüpfte PersonenHauptposition
Miscellaneous Commercial Services

David Pyott

Timothy Walbert

Mark Alles

Jean-Jacques Bienaimé

Peter Greenleaf

Mark Enyedy

Vassiliki Economides

Director/Board Member

Director/Board Member

Director/Board Member

Director/Board Member

Director/Board Member

Director/Board Member

Investor Relations Contact

Biotechnology

Wayne T. Pan

Jean-Jacques Bienaimé

Dan Spiegelman

Henry Fuchs

Robert Baffi

V. Lawlis

Alexander Hardy

Corporate Officer/Principal

Sales & Marketing

Treasurer

Corporate Officer/Principal

Director/Board Member

Corporate Officer/Principal

Chief Executive Officer

AMGEN INC. Pharmaceuticals: Major

Kathryn Falberg

Joseph Hagan

Eduardo Von Pervieux

Willard Dere

Massimiliano Colao

Daniel Billen

Director of Finance/CFO

Corporate Officer/Principal

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Corporate Officer/Principal

University of California, Los Angeles College/University

Kathryn Falberg

Athena Countouriotis

Dennis Joseph Slamon

Karen Smith

Massimiliano Colao

Undergraduate Degree

Undergraduate Degree

Corporate Officer/Principal

Doctorate Degree

Undergraduate Degree

Pharmaceuticals: Major

Timothy Walbert

Mark Alles

Jean-Jacques Bienaimé

Peter Greenleaf

Alexander Hardy

Director/Board Member

Director/Board Member

Director/Board Member

Director/Board Member

Director/Board Member

SUCAMPO PHARMACEUTICALS, INC. Pharmaceuticals: Major

Timothy Walbert

Peter Greenleaf

Matthew Donley

Karen Smith

Joseph Miller

Director/Board Member

Chief Executive Officer

Chief Tech/Sci/R&D Officer

Director/Board Member

Director of Finance/CFO

Medical Specialties

Mark Alles

Peter Greenleaf

Scott Habig

Elizabeth Anderson

Corporate Officer/Principal

Corporate Officer/Principal

Sales & Marketing

Director/Board Member

SPRUCE BIOSCIENCES, INC. Biotechnology

Dan Spiegelman

Michael Grey

Camilla Simpson

Javier Szwarcberg

Director/Board Member

Chairman

Director/Board Member

Chief Executive Officer

Medical Specialties

Jean-Jacques Bienaimé

Mark Enyedy

Jeff Ajer

Director/Board Member

Corporate Officer/Principal

Corporate Officer/Principal

Pharmaceuticals: Major

Michael Martin

Neil Solomons

Rashieda Gluck

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

Chief Tech/Sci/R&D Officer

Massachusetts Institute of Technology College/University

George Milne

Kevin Eggan

Elizabeth Ng

Doctorate Degree

Doctorate Degree

Undergraduate Degree

Biotechnology

George Milne

Peter Greenleaf

Matthew Donley

Director/Board Member

President

Human Resources Officer

Pharmaceuticals: Major

Henry Fuchs

Leonard Post

Traci McCarty

Chief Tech/Sci/R&D Officer

Chief Tech/Sci/R&D Officer

Investor Relations Contact

ELI LILLY AND COMPANY Pharmaceuticals: Major

Willard Dere

Barbara Bodem

Erin Burkhart

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Biotechnology

Jean-Jacques Bienaimé

Richard Ranieri

V. Lawlis

Chief Executive Officer

Human Resources Officer

Corporate Officer/Principal

HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY Pharmaceuticals: Major

Timothy Walbert

Michael Grey

Javier Szwarcberg

Chief Executive Officer

Director/Board Member

Chief Tech/Sci/R&D Officer

College/University

Barrie J. Carter

Lon Cardon

Edward Berg

Corporate Officer/Principal

Corporate Officer/Principal

Undergraduate Degree

The Wharton School of the University of Pennsylvania College/University

Ken Bate

Wayne T. Pan

Jean-Jacques Bienaimé

Masters Business Admin

Masters Business Admin

Masters Business Admin

University of California, Berkeley College/University

George Davis

DeDe Sheel

Sarah Noonberg

Undergraduate Degree

Undergraduate Degree

Doctorate Degree

MERCK & CO., INC. Pharmaceuticals: Major

Timothy Walbert

Elizabeth Ng

Edward Berg

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

GSK PLC Pharmaceuticals: Major

Geoffrey Nichol

Lon Cardon

Elizabeth Anderson

Corporate Officer/Principal

Corporate Officer/Principal

Director/Board Member

MIRUM PHARMACEUTICALS, INC. Pharmaceuticals: Major

Timothy Walbert

Michael Grey

Lon Cardon

Director/Board Member

Founder

Director/Board Member

TURG POIN Pharmaceuticals: Major

Mark Alles

Athena Countouriotis

Barbara Bodem

Chairman

Chief Executive Officer

Director/Board Member

College/University

Henry Fuchs

Kevin Eggan

Harold Bernstein

Undergraduate Degree

Corporate Officer/Principal

Undergraduate Degree

University of British Columbia College/University

Michael Hayden

R. MacKay-Dunn

Rashieda Gluck

Corporate Officer/Principal

Graduate Degree

Undergraduate Degree

BRISTOL-MYERS SQUIBB COMPANY Pharmaceuticals: Major

Athena Countouriotis

Karen Smith

Edward Berg

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Corporate Officer/Principal

Stanford University College/University

Dan Spiegelman

Elizabeth Ng

Marni Kottle

Undergraduate Degree

Masters Business Admin

Undergraduate Degree

The Trustees of Columbia University in The City of New York College/University

Vassiliki Economides

Simrat Randhawa

Graduate Degree

Masters Business Admin

INSMED INCORPORATED Pharmaceuticals: Major

Elaine Heron

Elizabeth Anderson

Director/Board Member

Director/Board Member

JOHNSON & JOHNSON Pharmaceuticals: Major

Jeffrey Bailey

Elizabeth Anderson

Sales & Marketing

Corporate Officer/Principal

Miscellaneous Commercial Services

Dan Spiegelman

Sarah Noonberg

Director/Board Member

Chief Tech/Sci/R&D Officer

The University of Colorado College/University

Robert Hombach

Lon Cardon

Undergraduate Degree

Doctorate Degree

Pharmaceuticals: Major

Elaine Heron

Michael Grey

Director/Board Member

Chief Executive Officer

Investment Managers

Dan Spiegelman

Robert Baffi

Private Equity Investor

Private Equity Investor

DIANTHUS THERAPEUTICS, INC. Biotechnology

Rashieda Gluck

Simrat Randhawa

Chief Tech/Sci/R&D Officer

Chief Tech/Sci/R&D Officer

BAVARIAN NORDIC A/S Pharmaceuticals: Major

Elaine Heron

Elizabeth Anderson

Director/Board Member

Director/Board Member

Medical Specialties

Kathryn Falberg

Scott Habig

Director/Board Member

Sales & Marketing

REVOLUTION MEDICINES, INC. Pharmaceuticals: Other

Elaine Heron

Elizabeth Anderson

Director/Board Member

Director/Board Member

University of Michigan College/University

Leonard Post

Matthew Donley

Corporate Officer/Principal

Undergraduate Degree

Biotechnology

Elaine Heron

Elizabeth Anderson

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

Elaine Heron

Elizabeth Anderson

Director/Board Member

Director/Board Member

HALOZYME THERAPEUTICS, INC. Biotechnology

Kathryn Falberg

Athena Countouriotis

Chairman

Chief Tech/Sci/R&D Officer

The Wall Street Journal CEO Council

Timothy Walbert

Alexander Hardy

Corporate Officer/Principal

Corporate Officer/Principal

KANE BIOTECH INC. Miscellaneous Commercial Services

Robert B. Huizinga

Rashieda Gluck

Chairman

Director/Board Member

VAXART, INC. Biotechnology

Elaine Heron

Edward Berg

Director/Board Member

General Counsel

College/University

Mark Enyedy

Joseph Hagan

Undergraduate Degree

Masters Business Admin

Pharmaceuticals: Major

Kathryn Falberg

Karen Smith

Director of Finance/CFO

Chief Tech/Sci/R&D Officer

Statistik

International

Vereinigte Staaten 43
Kanada 5
Schweiz 2
Irland 2
Vereinigtes Königreich 2

Sektoral

Health Technology 33
Consumer Services 12
Commercial Services 5
Finance 3

Operativ

Director/Board Member 481
Corporate Officer/Principal 191
Independent Dir/Board Member 183
Chief Tech/Sci/R&D Officer 90
Chief Executive Officer 81
  1. Börse
  2. Insiders
  3. Brinda Balakrishnan
  4. Unternehmensverbindungen
-40 % Zeitlich begrenztes Angebot: Unsere Abonnements führen Sie zu den besten Investitionen von morgen.
PROFITIEREN SIE JETZT